TNFRSF4 Produits
(Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories TNFRSF4 en vedette
TNFRSF4 Anticorps
High quality antibodies with extensive validation data.
TNFRSF4 Kits ELISA
Reliable ELISA kits for a wide range of species.
TNFRSF4 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
TNFRSF4 recommandé Anticorps
- (6)
- (7)
- (7)
- (4)
TNFRSF4 recommandé Kits ELISA
- (1)
- (1)
- (1)
TNFRSF4 recommandé Protéines
- (3)
- (3)
- (3)
Dernières publications sur nos produits TNFRSF4
: "Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist." dans: Journal for immunotherapy of cancer, Vol. 9, Issue 1, (2021) (PubMed).: "Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR." dans: mAbs, Vol. 12, Issue 1, pp. 1803646, (2020) (PubMed).
: "Crucial role of OX40/OX40L signaling in a murine model of asthma." dans: Molecular medicine reports, Vol. 17, Issue 3, pp. 4213-4220, (2018) (PubMed).
: "Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy." dans: Journal for immunotherapy of cancer, Vol. 6, Issue 1, pp. 149, (2018) (PubMed).
: "Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke." dans: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, (2015) (PubMed).
: "Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 7, pp. 3641-50, (2013) (PubMed).
: "Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. ..." dans: The Journal of experimental medicine, Vol. 210, Issue 9, pp. 1743-59, (2013) (PubMed).
: "Probing the interaction between feline immunodeficiency virus and CD134 by using the novel monoclonal antibody 7D6 and the CD134 (Ox40) ligand." dans: Journal of virology, Vol. 81, Issue 18, pp. 9665-79, (2007) (PubMed).
: "Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells." dans: Journal of leukocyte biology, Vol. 82, Issue 3, pp. 576-84, (2007) (PubMed).
: "Eosinophilic bowel disease controlled by the BB rat-derived lymphopenia/Gimap5 gene." dans: Gastroenterology, Vol. 131, Issue 5, pp. 1475-85, (2006) (PubMed).
Synonymes et noms alternatifs relatifs à TNFRSF4
TNF receptor superfamily member 4 (TNFRSF4), tumor necrosis factor receptor superfamily, member 4 (Tnfrsf4), TNF receptor superfamily member 4 (Tnfrsf4), ACT35, CD134, Ly-70, Ox40, OX40, TNFRSF4, Txgp1, TXGP1LProtein level used designations for TNFRSF4
- tumor necrosis factor receptor superfamily, member 4
- tumor necrosis factor receptor superfamily member 4
- OX40 antigen
- OX40L receptor
- tax-transcriptionally activated glycoprotein 1
- ACT35 antigen
- ATC35 antigen
- CD134 antigen
- OX40 cell surface antigen
- OX40 homologue
- TAX transcriptionally-activated glycoprotein 1 receptor
- lymphoid activation antigene ACT35
- tax-transcriptionally activated glycoprotein 1 receptor
- MRC OX40
- Tax-transcriptionally activated glycoprotein 1
- tumor necrosis factor (ligand) superfamily member 4
- tumor necrosis factor superfamily, member 4